Ingredient guides

Melatonin

Share

Email article

Published

Melatonin is a hormone that the brain makes in darkness. It is involved in the timing of the body's 24-hour rhythms and of sleep. Supplements come as tablets, capsules, gummies, liquids and lozenges, with immediate or extended release. Most melatonin in supplements is made synthetically.

Melatonin in the body

Melatonin is the main hormone of the pineal gland, a small gland deep in the brain. The gland makes it from the amino acid tryptophan, by way of serotonin. Its daily rise and fall gives the body's 24-hour rhythms a signal of night and day.

Terms and sources
pineal gland
Tordjman et al., Current Neuropharmacology, 2017.
by way of serotonin
Tryptophan becomes 5-hydroxytryptophan, then serotonin, then melatonin. Tordjman et al., Current Neuropharmacology, 2017.
24-hour rhythms
circadian rhythms. Melatonin rhythms are used as a marker of the body's internal time. Tordjman et al., Current Neuropharmacology, 2017.

Darkness increases melatonin production, and light at night reduces it. Signals about light travel from the eyes to the pineal gland through the brain's master clock. Release starts soon after sunset and peaks between 2 and 4 a.m. At night, blood levels are 80–120 pg/mL; in daytime, 10–20 pg/mL.

Terms and sources
light at night
NCCIH, melatonin fact sheet. Tordjman et al., Current Neuropharmacology, 2017.
master clock
the suprachiasmatic nucleus of the hypothalamus. Tordjman et al., Current Neuropharmacology, 2017.
80–120 pg/mL
picograms per milliliter of serum. About 80% of melatonin is made at night. Tordjman et al., Current Neuropharmacology, 2017.

The gut holds at least 400 times more melatonin than the pineal gland. The liver breaks down most melatonin; about 5% leaves in urine unchanged. Melatonin was first isolated in 1958, from cattle pineal glands.

Terms and sources
400 times
Cells of the gut lining also make melatonin. Tordjman et al., Current Neuropharmacology, 2017.
The liver
Tordjman et al., Current Neuropharmacology, 2017.
1958
By Aaron Lerner. Tordjman et al., Current Neuropharmacology, 2017.

Where melatonin comes from

Many foods contain melatonin, from picograms to milligrams per gram. Among animal foods, eggs and fish have more than meat. Among plant foods, nuts have the most, and mushrooms are also high. The highest reported value is in pistachios: 233,000 ng per gram of dry weight.

Terms and sources
picograms to milligrams
Amounts differ widely between foods, varieties and studies. Meng et al., Nutrients, 2017.
eggs and fish
Meng et al., Nutrients, 2017.
nuts
Meng et al., Nutrients, 2017.
233,000 ng
nanograms; about 0.23 mg per gram of dried pistachio. Meng et al., Nutrients, 2017.

Melatonin for supplements can come from animals or microorganisms. Most often, it is made synthetically.

Terms and sources
animals or microorganisms
NCCIH, melatonin fact sheet.

Daily amounts and the upper limit

A usual oral dose of 1–5 mg raises blood melatonin within an hour. Levels then reach 10–100 times the natural night peak. In one trial, 0.3 mg raised blood melatonin to its usual night level. After an immediate-release dose, blood levels peak in about 50 minutes. About 15% of a swallowed dose reaches the blood.

Terms and sources
1–5 mg
Tordjman et al., Current Neuropharmacology, 2017.
10–100 times
They return to daytime levels in 4–8 hours. Tordjman et al., Current Neuropharmacology, 2017.
In one trial
113 pg/mL. Zhdanova et al., Sleep, 1996.
about 50 minutes
Half of it is cleared in about 45 minutes. A review of 22 studies: Harpsøe et al., European Journal of Clinical Pharmacology, 2015.
About 15%
oral bioavailability; 9–33% across studies. Harpsøe et al., 2015.

NCCIH notes that information on side effects is not enough for a clear picture of overall safety. This applies especially to doses higher than the body normally makes. Short-term use of melatonin supplements “appears to be safe for most people,” NCCIH writes. Information on long-term use is lacking. Mild side effects reported in short-term studies included headache, dizziness, nausea and sleepiness. NCCIH advises people who take medicines to check with a health care provider before using melatonin.

Terms and sources
overall safety
NCCIH, melatonin fact sheet.
NCCIH writes
NCCIH, melatonin fact sheet.
short-term studies
A review cited by NCCIH: Andersen et al., Clinical Drug Investigation, 2016.

NCCIH notes that people with epilepsy and people taking blood thinners need medical supervision when taking melatonin. It also notes a possible risk of allergic reactions to melatonin supplements. Research on melatonin in pregnancy and breastfeeding is lacking, NCCIH notes. NCCIH advises people who are pregnant or breastfeeding to see a health care provider before taking melatonin. In older people, melatonin may stay active longer and cause daytime drowsiness. NCCIH cites a US sleep-medicine guideline that advises against melatonin for people with dementia. Some products may not contain what the label lists. In a study of 31 supplements cited by NCCIH, 26% contained serotonin. NCCIH writes that serotonin “can have harmful effects even at relatively low levels.”

Terms and sources
people taking blood thinners
NCCIH, melatonin fact sheet.
older people
NCCIH, melatonin fact sheet.
sleep-medicine guideline
American Academy of Sleep Medicine. NCCIH, melatonin fact sheet.
what the label lists
In a study of 25 gummy products sold in the US, 22 were labeled inaccurately. Cohen et al., JAMA, 2023, cited by NCCIH.

NCCIH advises parents to speak with a health care provider before giving melatonin to children. For short-term use at normal doses, melatonin supplements “appear to be safe for most children,” NCCIH writes. There are not many studies on children and melatonin, and little is known about long-term effects. Because melatonin is a hormone, NCCIH notes it might affect hormonal development. Examples are puberty, menstrual cycles and overproduction of the hormone prolactin. This is not known for sure. Side effects reported in children have usually been mild: drowsiness, increased bedwetting or evening urination, headache, dizziness and agitation. NCCIH notes that parents need to ensure safe storage and appropriate use of melatonin supplements. CDC estimated 11,000 emergency department visits in 2019–2022 for unsupervised melatonin intake by children 5 and younger. Many involved flavored products such as gummies. The CDC report stressed keeping medicines and supplements out of children's reach and sight. NCCIH notes that over-the-counter melatonin might place children and teenagers at risk for accidental or intentional overdose. US sales of melatonin rose about 150% between 2016 and 2020, a 2022 study cited by NCCIH found. Reports to US poison control centers for people 19 and younger rose from 8,337 in 2012 to 52,563 in 2021. Hospital stays and serious outcomes in this age group also rose. Most hospital stays involved teenagers who had intentionally taken overdoses. The largest rise in hospital stays was in children 5 and younger.

Terms and sources
CDC
US Centers for Disease Control and Prevention; a 2024 report cited by NCCIH.
poison control centers
Reports about melatonin; the number rose each year. A 2022 study cited by NCCIH.

United States

The National Academies have not set an upper limit for melatonin. There is no US recommended daily amount for melatonin. In the United States, melatonin is sold as a dietary supplement.

Terms and sources
upper limit
Melatonin is not among the nutrients in the Dietary Reference Intake tables. NIH Office of Dietary Supplements, nutrient recommendations.
dietary supplement
FDA rules for supplements are less strict than for prescription or over-the-counter drugs. NCCIH, melatonin fact sheet.

In our count, 2,880 US labels list melatonin; 55% of them list two or more ingredients. In 1,218 labels whose only ingredient is melatonin, the middle half list 3–5 mg per serving. The most common amounts are 3 mg (34% of labels), 5 mg (21%), 1 mg (15%) and 10 mg (14%). 19% list 1 mg or less; 4% list more than 10 mg, up to 60 mg. By form, 44% are tablets, 24% capsules, 12% gummies, 10% liquids and 5% lozenges. 76 labels (6%) name a slow, timed, sustained or extended release.

Terms and sources
2,880 US labels
NIH Dietary Supplement Label Database, including products no longer sold. Labels with melatonin in an ingredient or form name. Nutrition rows such as calories and sugars are not counted as ingredients. We counted these.
1,218 labels
Apart from nutrition rows such as calories and sugars. 1,213 state an amount in mg or mcg; we converted mcg to mg. 5 state only mL. A serving can be more than one tablet or gummy.
By form
As the database records the physical form. The rest are softgels, powders and other forms.
76 labels (6%)
Found in the product name or label text, read as release type. Labels that do not name the release type are not counted.

Upper limits in other countries: see the table of limits by country on this page.

Forms of melatonin and how they differ

All forms contain the same molecule; they differ in how fast it is released. Extended-release forms are also labeled time-release, sustained-release or prolonged-release. Some tablets have two layers, one fast and one slow. In one travel trial in a review, 2 mg slow-release melatonin was relatively ineffective. In one 28-day trial funded by its maker, 2 mg sustained-release melatonin differed from a dummy capsule. Lab tests found that labels and contents often differ. In a study of 31 supplements sold in Canada, content ranged from 83% below to 478% above the label. We do not rank forms.

Terms and sources
the same molecule
N-acetyl-5-methoxytryptamine, the name on some labels.
two layers
In our count of US labels.
relatively ineffective
Herxheimer and Petrie, Cochrane Database of Systematic Reviews, 2002.
funded by its maker
Thanawala et al., Clocks & Sleep, 2026. See the studies below.
labels and contents often differ
Erland and Saxena, Journal of Clinical Sleep Medicine, 2017; Cohen et al., JAMA, 2023. Both are cited by NCCIH.
31 supplements
8 of them (26%) also contained serotonin, another hormone. Erland and Saxena, 2017.
Melatonin tablets, extended-release, gummies, sublingual and liquid forms
FormHow it is takenWhat is known
Immediate-release tablet or capsuleSwallowedBlood levels peak in about 50 minutes; half is cleared in about 45 minutes (Harpsøe et al., 2015).
Extended-release (time-release, sustained, prolonged)SwallowedLabels name it time-release, sustained-release or prolonged-release; some tablets have a fast and a slow layer.
GummiesChewedOf 25 gummy products sold in the US, 22 were labeled inaccurately (Cohen et al., 2023, cited by NCCIH). One had no melatonin detected; the rest had 74–347% of the label.
Chewable tabletsChewedNot compared with swallowed forms in the sources on this page.
Sublingual and dissolving tablets, lozengesHeld in the mouthNot compared with swallowed forms in the sources on this page.
Liquids and spraysSwallowed or sprayed in the mouthNCCIH lists liquids among forms sold in the US. Not compared with other forms in the sources on this page.

Forms as named on labels. Amounts and times in the table are from the cited sources. Few labels name the release type.

Published studies of melatonin

8 studies: 4 found a difference, 1 found none, 2 had mixed results and 1 found more morning grogginess.

Terms and sources
8 studies
Travelers, night-shift workers and healthy volunteers. 5 of them used more than 1 mg.

Studies in adults without a diagnosis, each with our one-line summary.

Our one-line summary comes first. The original is on PubMed.

Show the studies
  • In 8 of 10 trials, air travelers had less jet lag with melatonin at bedtime than with a dummy product.

    Review · The abstract gives no total number of people. · Days after a flight

    Herxheimer and Petrie, Cochrane Database of Systematic Reviews, 2002

    Terms and sources
    8 of 10 trials
    Airline passengers, airline crews and military personnel, on flights across 5 or more time zones. One trial had a design fault and was not used in the assessment.
    melatonin at bedtime
    0.5–5 mg by mouth, close to the target bedtime at the destination (10 p.m. to midnight). Doses of 0.5–5 mg gave similar results; people fell asleep faster after 5 mg than after 0.5 mg. Doses above 5 mg seemed to give no more.
    a dummy product
    placebo

    Study · Free full text · about 47 min to read

    Our estimate at about 200 words a minute, from the PMC full text.

    Study summary

    Researchers combined 10 trials in air travelers, crews and military personnel. All compared melatonin taken by mouth with a dummy product. In 8 of the 10 trials, melatonin close to bedtime at the destination lowered jet lag ratings after long flights. Doses of 0.5–5 mg gave similar results; people fell asleep faster after 5 mg than after 0.5 mg. In one travel trial in the review, a 2 mg slow-release form was relatively ineffective. Taken early in the day, melatonin can cause sleepiness. Funding: the University of Auckland and Cochrane in the UK; one author ran two of the trials.

    • In 257 physicians flying from New York to Oslo, jet lag did not differ between melatonin and a dummy pill.

      Trial · 257 people · Travel day and 6 days · funding not stated

      Spitzer et al., American Journal of Psychiatry, 1999

      Also counted in Herxheimer 2002

      Terms and sources
      257 physicians
      Norwegian physicians returning from 5 days in New York, across 6 time zones eastward. The review notes they had not fully adapted to New York time.
      jet lag
      Rated on a new jet lag scale on the travel day and the next 6 days. Sleep onset, wake time, hours slept and naps did not differ either.
      melatonin
      Three plans: 5 mg at bedtime, 0.5 mg at bedtime, or 0.5 mg on a shifting schedule.
      a dummy pill
      placebo
      funding not stated
      The abstract does not name who paid. We could not read the full text.

      Study · Access not checked · about 2 min to read

      Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.

      Study summary

      Researchers compared three melatonin plans with a dummy pill in 257 Norwegian physicians. They flew home from New York to Oslo, across 6 time zones eastward. One group took 5 mg at bedtime, one 0.5 mg at bedtime and one 0.5 mg on a shifting schedule. Jet lag scores rose in all 4 groups on the first day home and then fell over 5 days. Scores did not differ between groups. Sleep onset, wake time, hours slept and naps did not differ either. Funding: not stated in the abstract.

  • In 7 trials of night-shift workers, melatonin lengthened daytime sleep by 24 minutes; time to fall asleep did not differ.

    Review · in the 7 trials of daytime sleep · Days after night shifts · funding not stated

    Liira et al., Cochrane Database of Systematic Reviews, 2014

    Terms and sources
    7 trials of night-shift workers
    Workers on night shifts in their current jobs, with or without sleep problems. Part of a review of 15 trials of several products.
    melatonin
    1–10 mg after the night shift, compared with a dummy product (placebo). The review found no difference by dose.
    by 24 minutes
    263 people; low-quality evidence. Night sleep was 17 minutes longer in 3 trials (234 people).
    time to fall asleep did not differ
    In 5 trials with 74 people; low-quality evidence.
    funding not stated
    The PMC copy we read does not show the review's own funding section. The review notes that drug makers funded 5 trials, none of melatonin.

    Study · Free full text · about 120 min to read

    Our estimate at about 200 words a minute, from the PMC full text.

    Study summary

    Researchers combined trials in people working night shifts. In 7 trials with 263 people, 1–10 mg melatonin after a night shift was compared with a dummy product. Daytime sleep was 24 minutes longer with melatonin. In 3 trials, night sleep was 17 minutes longer. Time to fall asleep did not differ in 5 trials with 74 people. The review rated the evidence as low quality. It found no difference between doses. Funding: the review's own funding section was not in the copy we read.

  • In 12 young adults, 0.3 or 1 mg melatonin at 9 p.m. shortened time to sleep versus a dummy pill.

    Trial · 12 people · Single evening doses · funding not stated

    Zhdanova et al., Sleep, 1996

    Terms and sources
    12 young adults
    Healthy volunteers with no sleep problems. Sleep was recorded in a lab from 10 p.m. to 7 a.m.
    shortened time to sleep
    Time to fall asleep and to light stage 2 sleep, measured with sleep recordings. Statistically significant. Sleep stages did not change.
    a dummy pill
    placebo. Morning mood and test scores showed no after-effects of either dose.
    funding not stated
    The abstract does not name who paid. We could not read the full text.

    Study · Access not checked · about 2 min to read

    Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.

    Study summary

    Researchers gave 12 healthy young volunteers 0.3 mg melatonin, 1 mg melatonin or a dummy pill at 9 p.m. That is 2–4 hours before their usual bedtime. Sleep was recorded in a lab overnight. With melatonin, people fell asleep sooner than with the dummy pill. The difference was statistically significant. Sleep stages did not change. The 0.3 mg dose raised blood melatonin to its usual night range. Morning mood and test scores showed no after-effects. Funding: not stated in the abstract.

  • In 6 men, melatonin at 6 or 8 p.m., not 9, shortened time to sleep versus a dummy pill.

    Trial · 6 people · Single evening doses · funding not stated

    Pires et al., Journal of Pineal Research, 2001

    Terms and sources
    6 men
    Healthy young volunteers aged 22–24. Sleep was recorded in a lab after each dose.
    melatonin
    0.3 or 1 mg, given at 6, 8 or 9 p.m. Morning sleepiness, mood and reaction time did not differ.
    not 9
    At 9 p.m., 0.3 mg lengthened the time to fall asleep and 1 mg had no effect.
    shortened time to sleep
    Measured with sleep recordings; statistically significant at 6 and 8 p.m.
    a dummy pill
    placebo
    funding not stated
    The abstract does not name who paid. We could not read the full text.

    Study · Access not checked · about 2 min to read

    Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.

    Study summary

    Researchers gave 6 healthy men aged 22–24 a dummy pill, 0.3 mg or 1 mg melatonin. Doses were taken at 6, 8 or 9 p.m., and sleep was recorded right after. Taken at 6 or 8 p.m., melatonin shortened the time to fall asleep. The difference was statistically significant. Taken at 9 p.m., 0.3 mg lengthened it, and 1 mg made no difference. Morning sleepiness, mood and reaction time did not differ. Funding: not stated in the abstract.

  • In 34 adults, 0.5 mg melatonin versus a dummy pill moved the body clock earlier or later, by intake time.

    Trial · 34 people · 3 days per session · maker-supplied

    Burgess et al., Journal of Clinical Endocrinology and Metabolism, 2010

    Terms and sources
    34 adults
    Healthy, 16 men and 18 women aged 18–42. Each spent two 5-day lab sessions, one with melatonin, one with a dummy pill. In the lab, 2.5 hours of dim light and 1.5 hours of dark alternated.
    a dummy pill
    placebo
    the body clock
    Measured as the time when melatonin starts to rise in the evening in dim light. Shifts with the dummy pill were subtracted.
    earlier or later
    On the fitted curve, up to 1.5 hours earlier with an afternoon dose, 2–4 hours before the evening rise. Up to 1.3 hours later with a dose soon after waking. A dose at bedtime shifted the clock little.
    maker-supplied
    Ecological Formulas donated the melatonin and dummy pills. A US National Institutes of Health grant paid for the work. The authors report nothing to disclose.

    Study · Free full text · about 24 min to read

    Our estimate at about 200 words a minute, from the PMC full text.

    Study summary

    Researchers studied 34 healthy adults aged 18–42 in a lab. In one session they took 0.5 mg melatonin once a day for 3 days, in another a dummy pill. An afternoon dose, 2–4 hours before the evening melatonin rise, moved the clock up to 1.5 hours earlier. Taken soon after waking, it moved the clock up to 1.3 hours later. Taken at bedtime, it shifted the clock little. A higher dose in the authors' earlier study gave shifts of similar size. Funding: a US government grant; a supplement maker donated the pills.

  • In 62 poor sleepers, 2 mg extended-release melatonin raised the share of the night asleep versus a dummy capsule.

    Trial · 59 analyzed · 28 days · maker-funded

    Thanawala et al., Clocks & Sleep, 2026

    Terms and sources
    62 poor sleepers
    Aged 30–60 in Pune, India, recruited at clinics. Poor sleep on a questionnaire. People whose poor sleep was linked to a psychiatric or other medical condition were excluded. So were shift workers and frequent long-haul travelers.
    2 mg extended-release melatonin
    One sustained-release capsule (Melotime) 30–60 minutes before bed.
    the share of the night asleep
    Share of time in bed spent asleep, measured at home with sleep sensors. It rose 3.5 points with melatonin and fell 6.3 with the dummy capsule. Total sleep time changed by +23.8 versus −39.3 minutes. Night waking and questionnaire scores from day 7 also differed; all statistically significant.
    a dummy capsule
    placebo. In this group, time to fall asleep rose by 17 minutes; with melatonin it fell by 10.
    maker-funded
    Nutriventia, which makes the tested capsules, paid for the study and made both kinds of capsules. 3 of the 6 authors work for it.

    Study · Free full text · about 35 min to read

    Our estimate at about 200 words a minute, from the PMC full text.

    Study summary

    Researchers compared 2 mg extended-release melatonin with a dummy capsule for 28 days. The 62 adults in India had poor sleep on a questionnaire. People whose poor sleep had another medical cause were excluded. Sleep was measured at home with sleep sensors. The share of the night spent asleep rose 3.5 points with melatonin and fell 6.3 with the dummy capsule. Time to fall asleep fell 10 minutes and rose 17 minutes. The authors note that the dummy group's sleep got poorer. Headaches and dizziness were similar in both groups. Funding: Nutriventia, the capsule maker; 3 authors work for it.

  • In 53 adults, nights with 6 mg melatonin were linked to more morning grogginess than nights with a dummy pill.

    Trial · 53 people · 8 nights · funding not stated

    Rose and Kahan, Journal of General Psychology, 2001

    Terms and sources
    53 adults
    21 men and 32 women aged 26–71. Researchers also varied what people were told they got.
    6 mg melatonin
    Over 8 nights, each person had nights with 6 mg melatonin and nights with a dummy pill. Sleep was rated every night.
    more morning grogginess
    Self-rated grogginess and tiredness on waking. People who got a dummy pill but expected melatonin also rated it higher.
    a dummy pill
    placebo
    funding not stated
    The abstract does not name who paid. We could not read the full text.

    Study · Access not checked · about 1 min to read

    Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.

    Study summary

    Researchers compared 6 mg melatonin with a dummy pill in 53 adults aged 26–71. Over 8 nights, each person had nights with each. They also varied what people were told they got. Each night, participants rated their sleep. People who took melatonin rated themselves groggier and more tired on waking. So did people who got a dummy pill but expected melatonin. Expecting melatonin, rather than taking it, went with higher ratings of unbroken sleep. Funding: not stated in the abstract.

Sources

Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.